Literature DB >> 10083505

Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.

W Kupin1, K K Venkat, M Goggins, V Douzdjian, F Escobar, M Mozes, M Abouljoud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10083505     DOI： 10.1016/s0041-1345(98)01933-2

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

Review 1.  Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.

Authors:  M Behrend
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Prospective controlled protocol for three months steroid withdrawal with tacrolimus, basiliximab, and mycophenolate mofetil in renal transplant recipients.

Authors:  Chang-Kwon Oh; Su Jin Kim; Ji Hye Kim; Jong Hoon Lee
Journal:  J Korean Med Sci       Date:  2012-03-21       Impact factor: 2.153
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.